Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock price
Equities
600196
CNE000000X38
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.13 CNY | +1.45% | -6.24% | -7.59% |
Sales 2024 * | 46.38B 6.42B | Sales 2025 * | 51.92B 7.19B | Capitalization | 55.57B 7.69B |
---|---|---|---|---|---|
Net income 2024 * | 3.84B 531M | Net income 2025 * | 4.54B 628M | EV / Sales 2024 * | 1.54 x |
Net Debt 2024 * | 15.73B 2.18B | Net Debt 2025 * | 13.35B 1.85B | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
15.8
x | P/E ratio 2025 * |
13.3
x | Employees | 38,399 |
Yield 2024 * |
1.73% | Yield 2025 * |
2.09% | Free-Float | 63.42% |
1 day | +1.45% | ||
1 week | -6.24% | ||
Current month | -5.90% | ||
1 month | -4.30% | ||
3 months | -7.26% | ||
6 months | -19.13% | ||
Current year | -7.59% |
Managers | Title | Age | Since |
---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Dong Ming Li
PSD | President | 55 | 20-10-28 |
Yi Fang Wu
CHM | Chairman | 54 | 04-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-04-08 |
Qi Yu Chen
BRD | Director/Board Member | 51 | 94-03-31 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.27% | 2 M€ | -16.09% | - | |
1.18% | 4 M€ | -2.96% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 23.13 | +1.45% | 9,996,330 |
24-03-27 | 22.8 | -3.14% | 12,704,970 |
24-03-26 | 23.54 | -0.25% | 8,946,292 |
24-03-25 | 23.6 | -2.07% | 9,027,222 |
24-03-22 | 24.1 | -2.31% | 11,756,600 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.59% | 7.59B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |